These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8071933)
1. Structure-activity relationships of 1,2,4-triazolo[1,5-a] quinoxalines and their 1-deaza analogues imidazo[1,2-a]quinoxalines at the benzodiazepine receptor. Catarzi D; Cecchi L; Colotta V; Melani F; Filacchioni G; Martini C; Giusti L; Lucacchini A J Med Chem; 1994 Sep; 37(18):2846-50. PubMed ID: 8071933 [TBL] [Abstract][Full Text] [Related]
2. Tricyclic heteroaromatic systems. 1,2,4-triazolo[4,3-a]quinoxalines and 1,2,4-Triazino[4,3-a]quinoxalines: synthesis and central benzodiazepine receptor activity. Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C Arch Pharm (Weinheim); 1997 Dec; 330(12):387-91. PubMed ID: 9474898 [TBL] [Abstract][Full Text] [Related]
3. Tricyclic heteroaromatic systems 1,2,4-triazolo[1,5-a]quinoxalines: synthesis and benzodiazepine receptor activity. Catarzi D; Cecchi L; Colotta V; Melani F; Filacchioni G; Martini C; Giusti L; Lucacchini A Farmaco; 1993 Aug; 48(8):1065-78. PubMed ID: 8216669 [TBL] [Abstract][Full Text] [Related]
4. Studies on annelated 1,4-benzothiazines and 1,5-benzothiazepines. VII. Synthesis and inhibition of benzodiazepine receptor binding of some 4,5-dihydro-tetrazolo[5,1-d]-1,5-benzothiazepines and 5-phenyl-s-triazolo[3,4-d]-1,5-benzothiazepines. Ambrogi V; Grandolini G; Perioli L; Giusti L; Lucacchini A; Martini C Farmaco; 1993 May; 48(5):665-76. PubMed ID: 8393678 [TBL] [Abstract][Full Text] [Related]
5. New 1,2,3-triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors. II. Biagi G; Giorgi I; Livi O; Scartoni V; Betti L; Giannaccini G; Trincavelli ML Eur J Med Chem; 2002 Jul; 37(7):565-71. PubMed ID: 12126775 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-ones. Francis JE; Cash WD; Barbaz BS; Bernard PS; Lovell RA; Mazzenga GC; Friedmann RC; Hyun JL; Braunwalder AF; Loo PS J Med Chem; 1991 Jan; 34(1):281-90. PubMed ID: 1846920 [TBL] [Abstract][Full Text] [Related]
7. Two imidazoquinoxaline ligands for the benzodiazepine site sharing a second low affinity site on rat GABA(A) receptors but with the opposite functionality. Im HK; Im WB; Pregenzer JF; Stratman NC; VonVoigtlander PF; Jacobsen EJ Br J Pharmacol; 1998 Apr; 123(8):1490-4. PubMed ID: 9605552 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of some 2-aryl-1,2,4-triazolo[1,5-c][1,3]benzoxazin-5-ones as tools to define the essential pharmacophoric descriptors of a benzodiazepine receptor ligand. Catarzi D; Cecchi L; Colotta V; Filacchioni G; Varano F; Martini C; Giousti L; Lucacchini A J Med Chem; 1995 Jun; 38(12):2196-201. PubMed ID: 7783151 [TBL] [Abstract][Full Text] [Related]
9. High-affinity partial agonist imidazo[1,5-a]quinoxaline amides, carbamates, and ureas at the gamma-aminobutyric acid A/benzodiazepine receptor complex. Jacobsen EJ; TenBrink RE; Stelzer LS; Belonga KL; Carter DB; Im HK; Im WB; Sethy VH; Tang AH; VonVoigtlander PF; Petke JD J Med Chem; 1996 Jan; 39(1):158-75. PubMed ID: 8568803 [TBL] [Abstract][Full Text] [Related]
10. Tricyclic heteroaromatic systems pyrazolo[1,5-a]quinoxalines: synthesis and benzodiazepine receptor activity. Colotta V; Cecchi L; Catarzi D; Conti G; Filacchioni G; Martini C; Giusti L; Lucacchini A Farmaco; 1993 Aug; 48(8):1051-63. PubMed ID: 8216668 [TBL] [Abstract][Full Text] [Related]
11. 4-Amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo [4,3-alpha]-quinoxalin-1-one: a new A2A adenosine receptor antagonist with high selectivity versus A1 receptors. Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A Arch Pharm (Weinheim); 1999 Feb; 332(2):39-41. PubMed ID: 10233008 [No Abstract] [Full Text] [Related]
12. 1-substituted 4-[chloropyrazolyl][1,2,4]triazolo[4,3-a]quinoxalines: synthesis and structure-activity relationships of a new class of benzodiazepine and adenosine receptor ligands. Matuszczak B; Pekala E; Müller CE Arch Pharm (Weinheim); 1998 May; 331(5):163-9. PubMed ID: 9691247 [TBL] [Abstract][Full Text] [Related]
13. Unraveling the identity of benzodiazepine binding sites in rat hipppocampus and olfactory bulb. Lameh J; Wang P; Elgart D; Meredith D; Shafer SL; Loew GH Eur J Pharmacol; 2000 Jul; 400(2-3):167-76. PubMed ID: 10988330 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists. Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Traini C; Pugliese AM; Pedata F; Morizzo E; Moro S Bioorg Med Chem; 2008 Jun; 16(11):6086-102. PubMed ID: 18468446 [TBL] [Abstract][Full Text] [Related]
15. Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality. Jacobsen EJ; Stelzer LS; TenBrink RE; Belonga KL; Carter DB; Im HK; Im WB; Sethy VH; Tang AH; VonVoigtlander PF; Petke JD; Zhong WZ; Mickelson JW J Med Chem; 1999 Apr; 42(7):1123-44. PubMed ID: 10197957 [TBL] [Abstract][Full Text] [Related]
16. Antagonist, partial agonist, and full agonist imidazo[1,5-a]quinoxaline amides and carbamates acting through the GABAA/benzodiazepine receptor. TenBrink RE; Im WB; Sethy VH; Tang AH; Carter DB J Med Chem; 1994 Mar; 37(6):758-68. PubMed ID: 8145225 [TBL] [Abstract][Full Text] [Related]
17. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. Sarges R; Howard HR; Browne RG; Lebel LA; Seymour PA; Koe BK J Med Chem; 1990 Aug; 33(8):2240-54. PubMed ID: 2374150 [TBL] [Abstract][Full Text] [Related]